Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04085978 · ClinicalTrials.gov registry record
Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission
A clinical trial, sponsored by Pediatrix.
- Terminated
- Registry status
- 400
- Enrollment target
NCT04085978: Clinical Trial study, sponsored by Pediatrix.
NCT04085978 is a clinical trial that was terminated before completion, run by Pediatrix. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04085978 was terminated before completion, sponsored by Pediatrix.
- TERMINATED
- Registry status
- 400 participants
- Enrollment target
Study Summary
Evaluate if the implementation of a hypoglycemia protocol with glucose gel has reduced the NICU admission rate of neonates with low-acuity neonatal hypoglycemia.
Primary Outcome
Mean NICU length of stay rounded to the day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2020-05-04 |
| Est. Completion | 2020-10-12 |
Why NCT04085978 stopped before completion
NCT04085978 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04085978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04085978 about?
NCT04085978 is a clinical study titled "Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission". Evaluate if the implementation of a hypoglycemia protocol with glucose gel has reduced the NICU admission rate of neonates with low-acuity neonatal hypoglycemia.
What is the current status of trial NCT04085978?
This trial is currently terminated. The enrollment target is 400 participants. The study started on 2020-05-04. Estimated completion is 2020-10-12.
Who is sponsoring clinical trial NCT04085978?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI